Residents in eastern Congo cling to hope as a new Ebola treatment trial begins
Researchers have launched a clinical trial in eastern Congo to test experimental treatments for the Bundibugyo Ebola virus. The study involves international health organizations and aims to improve survival rates for patients in the outbreak zone.
Why it matters
This trial represents a critical effort to combat a deadly, less-understood strain of Ebola in a high-risk region.
Residents at the epicenter of Congo's Ebola outbreak are pinning their hopes on experimental treatments after researchers began a highly anticipated study in early July of two possible Ebola treatments in hopes of fighting the still-growing outbreak.
The article provides a factual, objective report on medical research and public health efforts.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in